HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
JNJ
Johnson & Johnson
Healthcare Drug Manufacturers - General · New Jersey, USA · Reports in usd
Market Cap: $564.21B
Market Cap
$564.21B
Enterprise Val
$592.04B
P/E Ratio
21.05
P/B Ratio
6.92
Trailing PEG (1Y)
0.43
As Of
Apr 16, 2026

Overview & Key Metrics

Reporting period: Dec 28, 2025 · Q4 2025
Book Value$81.54B
Gross Margin67.56%
Profit Margin67.56%
Return on Equity33.78%
Return on Assets13.76%
Current Ratio1.03
Debt/Equity0.59
LT Debt/Equity0.48
Revenue Per Share10.20

Income Statement

Dec 28, 2025
Revenue$24.56B
Cost of Revenue$7.97B
Gross Profit$16.60B
R&D$4.25B
SG&A$6.75B
Operating Expenses$11.17B
Operating Income$5.43B
Interest Expense$214.0M
Tax Expense-$150.0M
Net Income$5.12B
EPS (Basic)$2.12
EPS (Diluted)$2.09
EBIT$5.18B
EBITDA$7.19B
Consolidated Income$5.12B
Non-Controlling Interests$0.00

Balance Sheet

Dec 28, 2025
Cash & Equivalents$19.71B
Accounts Receivable$17.18B
Inventory$14.19B
Current Assets$55.62B
LT Investments$0.00
Property, Plant & Equipment$23.17B
Intangibles$99.18B
Non-Current Assets$143.59B
Total Assets$199.21B
Accounts Payable$11.99B
Current Debt$8.50B
Current Liabilities$54.13B
LT Debt$39.44B
Non-Current Liabilities$63.54B
Total Liabilities$117.67B
Total Debt$47.93B
Retained Earnings$168.98B
Shareholder Equity$81.54B
Shares Outstanding2,409,295,102

Cash Flow Statement

Dec 28, 2025
Operating Cash Flow$7.31B
Investing Cash Flow-$4.49B
Financing Cash Flow-$1.37B
CapEx-$1.84B
Free Cash Flow$5.47B
Depreciation & Amort.$2.01B
Stock-Based Comp$309.0M
Acquisitions / Disposals-$2.77B
Investment Activity$185.0M
Debt Issued/Repaid$2.13B
Equity Issued/Repaid-$337.0M
Dividends Paid-$3.13B
Net Change in Cash$1.48B
Data cached · Meta live · Daily live · Statements live · TTL 24h